Arkolith/Insider Trading/SRPT/Form 4

Barry Richard

DirectorSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed May 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2025Option exercise(M)10K$25.18$245K2.9M
May 13, 2025Option exercise(M)11K$13.71$144K3.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 13, 2025Option exercise(M)10K—$00
May 13, 2025Option exercise(M)11K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-071961) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML